
Eris Lifesciences Q2 FY27 Results: Consolidated Net Profit ₹187 Crore on Total Income of ₹896 Crore
Eris Lifesciences (NSE: ERIS) reported consolidated total income of ₹895.57 crore and net profit of ₹187.14 crore for the quarter ended 30 Sep 2026, it said in a filing on 26 Oct 2026. Standalone total income was ₹501.48 crore and standalone net profit ₹129.15 crore.
- Earnings
- Pharmaceuticals